Ensemble Innovation Ventures Fund (EIVF) will target the health and wellness space.

Dexcom Ventures will invest in glucose sensing technology and adjacent areas.

Chris Chai and Peter Van Vlasselaer, both former executives at SR One portfolio companies, have been hired by the GSK-backed VC firm as venture partners.

Alphabet's GV unit and Huami both took part as the portable MRI device developer completed an oversubscribed series D round.

The Lepu-backed genetic cancer therapy developer has completed a $94.9m round co-led by CICC Capital, Share Capital, Vertex Ventures China and Qianhai FOF.

Cleva Pharma Capital backed a series C round that will support the clinical progress of drug candidates for sensorineural hearing loss and multiple sclerosis.

Returning backer Novo was among the investors in a series C round for the synthetic cancer treatment developer that was led by RA Capital Management.

Today's deal net contains news from RAW Labs, Neuropain Therapeutics and Swajal.

Swisscom Ventures participated in a round that lifted the total raised by the laboratory simulation software provider to $104m.

The life sciences research technology developer has received funding in a series A round co-led by corporate investor ABclonal.